Accueil   Diary - News   All news Valneva announces generation of a highly-purified Zika vaccine candidate

Valneva announces generation of a highly-purified Zika vaccine candidate

valvena photos pied de pageValneva SE (“Valneva” or “the Company”), a leading pure play vaccine company, today announced that it successfully generated a highly purified inactivated vaccine candidate against the Zika virus (ZIKV). The candidate was developed using the same manufacturing platform as the Company’s Japanese encephalitis vaccine, a vaccine which has already been approved by the American (FDA, Health Canada), European (EMA) and other regulatory agencies and is today commercialized in the US, Europe, Canada, and other territories under the tradenames IXIARO®/ JESPECT®.



Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to More details are available by clicking here I agree